MR编号 | PT/H/0186/003 |
---|
药品名称 | Ceftazidime Kabi |
---|
活性成分 | |
---|
剂型 | Powder for solution for injection |
---|
上市许可持有人 | Fresenius Kabi Pharma Portugal, Lda.
Av. do Forte, 3 - Edifício Suécia I - Piso 2 Carnaxide |
---|
参考成员国 - 产品名称 | Portugal (PT) |
---|
互认成员国 - 产品名称 | - Germany (DE)
Ceftazidim Kabi 2 g Pulver zur Herstellung einer Injketionslösung oder Infusionslösung - Denmark (DK)
Ceftazidom "Fresenius Kabi" - Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Austria (AT)
Ceftazidim Kabi 0,5 g Pulver zur Herstellung einer Injektionslösung - Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Ceftazidime Kabi - Latvia (LV)
Ceftazidime Fresenius Kabi 2000 mg pulveris injekciju vai infūziju šķīduma pagatavošanai - Lithuania (LT)
Ceftazidime Kabi 2000 mg milteliai injekciniam arba infuziniam tirpalui - Estonia (EE)
CEFTAZIDIME FRESENIUS KABI 2000MG - Hungary (HU)
CEFTAZIDIM KABI 2 g por oldatos injekcióhoz vagy infúzióhoz - Czechia (CZ)
- Slovakia (SK)
Ceftazidim Kabi 2g - Slovenia (SI)
- Malta (MT)
- Iceland (IS)
- Italy (IT)
|
---|
许可日期 | 2008/10/22 |
---|
最近更新日期 | 2024/12/07 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|